![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[Article Abstract]](/e/graphics/abstractborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hb5124contents.gif)
Acta Cryst. (2009). E65, m1334 [ doi:10.1107/S1600536809040185 ]
![[mu]](/logos/entities/mu_rmgif.gif)
2-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylato]cobalt(II)] dihydrate]Online 10 October 2009
Copyright © International Union of Crystallography
IUCr Webmaster